Dutch CRO establishes German subsidiary, office in Frankfurt

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Panama7)
(Image: Getty/Panama7)

Related tags: SMS-Oncology, CRO, Oncology

The Netherlands-based contract research organization SMS-Oncology establishes a German subsidiary with new offices in Frankfurt.

The new entity – SMS-Oncology GmbH – will be led by Raymond Hoffmans, who said, “Management team chose Frankfurt because of its central location in Germany and a good infrastructure,”​ including an international airport, train, and highway systems.

“In addition, there is a strong ecosystem of life science companies in Frankfurt and the surrounding area,”​ Hoffmans told us.

The company is already performing studies at sites in Germany, so opening an office in this location “was the next logical step for company’s growth and expansion plans,”​ he said.

The contract research organization (CRO), dedicated to oncology, operates in more than 20 countries, and has a local presence in the Nordics and Spain, in addition to the new Germany-based office.

Hoffmans, managing director of SMS-Oncology GmbH, has been the chief business development offices at SMS-Oncology since 2014. He received his PhD from the University of Zurich and joined the Dana Farber Cancer Institute in Boston, MA in the US as a postdoctoral research fellow.

Related news

Show more

Related products

show more

Using SDTM, ADaM, and SEND

Using SDTM, ADaM, and SEND

Formedix | 09-Nov-2022 | Technical / White Paper

This article gives an overview of SDTM, ADaM, SEND and ARM, and discusses how these CDISC standards fit in with the wider clinical trial process, and how...

How to design an effective CRF

How to design an effective CRF

Formedix | 10-Oct-2022 | Technical / White Paper

CRFs and eCRFs are used for gathering patient data during clinical trials. They play a crucial role in helping to assess the safety and efficacy of clinical...

The Complexities of Ophthalmic Drug Development

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

Because When It's On the Line... Capability Matters.

Because When It's On the Line... Capability Matters.

Baxter BioPharma Solutions | 01-Oct-2022 | Product Brochure

Baxter’s BioPharma Solutions business supports leading pharmaceutical companies in meeting their commercialization objectives by providing scientific expertise,...

Related suppliers

Follow us


View more